Neuropace Inc (NPCE)

Neuropace Inc (NPCE) is a Medical Devices company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $435M; returns 1 day -1.8%, 1 week +5.5%, 1 year +22.4%.

NeuroPace Inc. (NPCE) is a medical device company specializing in neuromodulation therapies for epilepsy patients. Its primary product is the RNS System, a responsive neurostimulation device implanted in the brain that detects abnormal electrical activity and delivers targeted stimulation to prevent or interrupt seizures in real-time.

Groups NPCE belongs to

NPCE financial model: income statement, cash flow and balance sheet